Further, we show <i>RAPGEF1</i> expression is significantly enriched in melanomas lacking strongly activating RAS-MAPK mutations, suggesting that <i>RAPGEF1</i> may promote oncogenic RAS-MAPK signaling in melanomas. This evidence concerns the gene RAPGEF1 and melanoma.